University of Calgary research team has discovered a groundbreaking method for transforming limestone into a bacteria-killing nanoparticle
- Yana
- Jun 11
- 1 min read
Biosenta's groundbreaking Tri-Filler™ nanoparticles have demonstrated a remarkable 100% effectiveness in eliminating a range of high-priority pathogens, as recognized by the World Health Organization (WHO). This significant achievement, detailed in a recent press release, marks a major step forward in the fight against dangerous bacteria.
The studies, conducted at the University of Calgary and published in two separate peer-reviewed journals, Colloids and Surfaces A and The Canadian Journal of Chemical Engineering, confirmed the potent bactericidal activity of the Tri-Filler™ nanoparticles. The nanoparticles were successful in eradicating both gram-negative bacteria, such as Escherichia coli (E. coli) and Pseudomonas aeruginosa, and gram-positive bacteria, including the notorious methicillin-resistant Staphylococcus aureus (MRSA).
What makes this breakthrough even more promising is that the Tri-Filler™ nanoparticles achieved this complete elimination at a relatively low concentration, a significant advantage over traditional biocides that often require higher doses and can lead to resistance and toxicity. The company has also seen encouraging results against other harmful microbes, such as fungi.
With these compelling results, Biosenta is now moving forward with regulatory submissions to Health Canada and the U.S. Environmental Protection Agency (EPA) for products incorporating the Tri-Filler™ technology. The company is also in the process of designing a full-scale commercial production plant.
This milestone is not just a scientific achievement but also a personal mission for Biosenta's President and CEO, Am Gill, who was inspired to start the company after his uncle's tragic death from a hospital-acquired infection.
Comments